Who Owns ADXN?

Addex Therapeutics Ltd — Institutional Ownership & 13F Holdings

$6.90

-0.10 (-1.43%)

Market Cap

$4.8M

Shares Outstanding

660,575

Institutional Holders

5

Total Inst. Value

$1.3M

% of Float Held

QoQ Holder Change

+3

Institutional data as of Q1 2025

New Positions

0

Closed Positions

1

Increased

1

Decreased

3

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1GAMMA Investing LLC$1.2M8,757
2CITADEL ADVISORS LLC$86K11,741
3RHUMBLINE ADVISERS$52872
4SBI Securities Co., Ltd.$375
5MORGAN STANLEY$0100

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue
GAMMA Investing LLC+8K$1.2M

Top Sellers

FundShares RemovedValue
MORGAN STANLEY-2K$0
CITADEL ADVISORS LLC-338$86K
RHUMBLINE ADVISERS-35$528

Related Stocks

Frequently Asked Questions

How many institutional investors hold ADXN?

As of Q1 2025, 5 institutional investors report holding ADXN (Addex Therapeutics Ltd) in their 13F filings.

Which hedge fund owns the most ADXN?

The largest institutional holder of ADXN is GAMMA Investing LLC with $1.2M in shares.

Are institutions buying or selling ADXN?

This quarter, 0 institutions opened new positions in ADXN and 1 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.